• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Evaluation and Management of Secondary Hypertension.继发性高血压的评估与管理。
Med Clin North Am. 2022 Mar;106(2):269-283. doi: 10.1016/j.mcna.2021.11.004. Epub 2022 Feb 2.
2
Obstructive sleep apnea: the most common secondary cause of hypertension associated with resistant hypertension.阻塞性睡眠呼吸暂停:与难治性高血压相关的最常见的继发性高血压病因。
Hypertension. 2011 Nov;58(5):811-7. doi: 10.1161/HYPERTENSIONAHA.111.179788. Epub 2011 Oct 3.
3
[Obstructive sleep apnea and drugs as causes of treatment-resistant hypertension].[阻塞性睡眠呼吸暂停和药物作为难治性高血压的病因]
Rev Med Suisse. 2012 Jan 11;8(323):28-30.
4
Resistant Hypertension: Diagnosis and Management.耐药性高血压:诊断与管理。
Adv Chronic Kidney Dis. 2019 Mar;26(2):99-109. doi: 10.1053/j.ackd.2019.03.002.
5
Sleep apnea, hypertension, and hemorrhagic stroke-déjà vu all over again.睡眠呼吸暂停、高血压和出血性中风——似曾相识的情况再次出现。
J Am Soc Hypertens. 2016 Mar;10(3):197-200. doi: 10.1016/j.jash.2016.01.018. Epub 2016 Jan 30.
6
Resistant hypertension: diagnosis, evaluation, and treatment: a scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research.顽固性高血压:诊断、评估与治疗:美国心脏协会高血压研究理事会专业教育委员会的科学声明
Circulation. 2008 Jun 24;117(25):e510-26. doi: 10.1161/CIRCULATIONAHA.108.189141.
7
Resistant hypertension: diagnosis, evaluation, and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research.难治性高血压:诊断、评估与治疗。美国心脏协会高血压研究理事会专业教育委员会的科学声明。
Hypertension. 2008 Jun;51(6):1403-19. doi: 10.1161/HYPERTENSIONAHA.108.189141. Epub 2008 Apr 7.
8
Characterization and treatment of resistant hypertension.耐药性高血压的特征与治疗。
Curr Cardiol Rep. 2009 Nov;11(6):407-13. doi: 10.1007/s11886-009-0059-z.
9
Screening for sleep apnea in patients with resistant hypertension.顽固性高血压患者的睡眠呼吸暂停筛查。
Am J Hypertens. 2008 Jul;21(7):728. doi: 10.1038/ajh.2008.193.
10
Comparative Efficacy of Continuous Positive Airway Pressure and Antihypertensive Medications in Obstructive Sleep Apnea-Related Hypertension: A Narrative Review.持续气道正压通气与抗高血压药物治疗阻塞性睡眠呼吸暂停相关性高血压的疗效比较:一项叙述性综述
High Blood Press Cardiovasc Prev. 2025 Mar;32(2):127-137. doi: 10.1007/s40292-024-00691-9. Epub 2024 Dec 24.

引用本文的文献

1
Causal Relationship Between Air Pollutants and Blood Pressure Phenotypes: A Mendelian Randomization Study.空气污染物与血压表型之间的因果关系:一项孟德尔随机化研究
Glob Heart. 2025 Feb 24;20(1):18. doi: 10.5334/gh.1404. eCollection 2025.
2
Acute Hepatic Porphyria Should Be Included in the Diagnostic Work-Up of Patients with Resistant Hypertension or Suspected Secondary Hypertension.急性肝卟啉病应纳入难治性高血压或疑似继发性高血压患者的诊断检查中。
Med Sci (Basel). 2025 Feb 6;13(1):14. doi: 10.3390/medsci13010014.
3
Global, regional, and national disease burden attributable to high systolic blood pressure in youth and young adults: 2021 Global Burden of Disease Study analysis.青年和年轻成年人中高收缩压所致的全球、区域和国家疾病负担:2021年全球疾病负担研究分析
BMC Med. 2025 Feb 6;23(1):74. doi: 10.1186/s12916-025-03918-1.
4
A new potential cause of secondary hypertension.继发性高血压的一种新的潜在病因。
Front Cardiovasc Med. 2024 Aug 29;11:1458089. doi: 10.3389/fcvm.2024.1458089. eCollection 2024.
5
The Global Burden of Resistant Hypertension and Potential Treatment Options.难治性高血压的全球负担及潜在治疗方案
Eur Cardiol. 2024 Jun 19;19:e07. doi: 10.15420/ecr.2023.51. eCollection 2024.
6
Advances in the Pathogenesis and Treatment of Resistant Hypertension.耐药性高血压的发病机制与治疗进展。
Int J Mol Sci. 2023 Aug 18;24(16):12911. doi: 10.3390/ijms241612911.
7
Adjuvant music therapy for patients with hypertension: a meta-analysis and systematic review.辅助音乐疗法治疗高血压患者的 Meta 分析和系统评价。
BMC Complement Med Ther. 2023 Apr 6;23(1):110. doi: 10.1186/s12906-023-03929-6.
8
Etiological Diagnosis and Personalized Therapy for Hypertension: A Hypothesis of the REASOH Classification.高血压的病因诊断与个体化治疗:REASOH分类假说
J Pers Med. 2023 Jan 30;13(2):261. doi: 10.3390/jpm13020261.
9
Clinical identification of expressed proteins in adrenal medullary hyperplasia detected with hypertension.临床识别高血压伴肾上腺髓质增生中表达的蛋白质。
Front Endocrinol (Lausanne). 2022 Dec 13;13:1014366. doi: 10.3389/fendo.2022.1014366. eCollection 2022.

本文引用的文献

1
Testing for Primary Aldosteronism and Mineralocorticoid Receptor Antagonist Use Among U.S. Veterans : A Retrospective Cohort Study.在美国退伍军人中进行原发性醛固酮增多症和盐皮质激素受体拮抗剂检测:一项回顾性队列研究。
Ann Intern Med. 2021 Mar;174(3):289-297. doi: 10.7326/M20-4873. Epub 2020 Dec 29.
2
The Unrecognized Prevalence of Primary Aldosteronism.原发性醛固酮增多症未被认识的患病率
Ann Intern Med. 2020 Oct 20;173(8):683. doi: 10.7326/L20-1097.
3
Diagnosis and Management of Obstructive Sleep Apnea: A Review.阻塞性睡眠呼吸暂停的诊断和治疗:综述。
JAMA. 2020 Apr 14;323(14):1389-1400. doi: 10.1001/jama.2020.3514.
4
Hypertension in Cancer Patients and Survivors: Epidemiology, Diagnosis, and Management.癌症患者及幸存者中的高血压:流行病学、诊断与管理
JACC CardioOncol. 2019 Dec;1(2):238-251. doi: 10.1016/j.jaccao.2019.11.009. Epub 2019 Dec 17.
5
Screening Rates for Primary Aldosteronism in Resistant Hypertension: A Cohort Study.原发性醛固酮增多症在耐药性高血压中的筛查率:一项队列研究。
Hypertension. 2020 Mar;75(3):650-659. doi: 10.1161/HYPERTENSIONAHA.119.14359. Epub 2020 Feb 3.
6
Obstructive Sleep Apnea, Hypertension, and Cardiovascular Risk: Epidemiology, Pathophysiology, and Management.阻塞性睡眠呼吸暂停、高血压和心血管风险:流行病学、病理生理学和管理。
Curr Cardiol Rep. 2020 Jan 18;22(2):6. doi: 10.1007/s11886-020-1257-y.
7
Non-steroidal anti-inflammatory drug (NSAID) therapy in patients with hypertension, cardiovascular, renal or gastrointestinal comorbidities: joint APAGE/APLAR/APSDE/APSH/APSN/PoA recommendations.伴有高血压、心血管、肾脏或胃肠道合并症的患者的非甾体抗炎药(NSAID)治疗:APAGE/APLAR/APSDE/APSH/APSN/PoA 联合推荐。
Gut. 2020 Apr;69(4):617-629. doi: 10.1136/gutjnl-2019-319300. Epub 2020 Jan 14.
8
Obstructive Sleep Apnea.阻塞性睡眠呼吸暂停。
Ann Intern Med. 2019 Dec 3;171(11):ITC81-ITC96. doi: 10.7326/AITC201912030.
9
Drug-Induced Hypertension.药物性高血压。
Endocrinol Metab Clin North Am. 2019 Dec;48(4):859-873. doi: 10.1016/j.ecl.2019.08.013. Epub 2019 Sep 17.
10
Renovascular Hypertension.肾血管性高血压。
Endocrinol Metab Clin North Am. 2019 Dec;48(4):765-778. doi: 10.1016/j.ecl.2019.08.007. Epub 2019 Sep 19.

继发性高血压的评估与管理。

Evaluation and Management of Secondary Hypertension.

机构信息

Division of Nephrology and Hypertension, Zuckerberg San Francisco General Hospital, University of California San Francisco, 1001 Potrero Avenue, San Francisco, CA 94110, USA. Electronic address: https://twitter.com/hurryknee.

Renal-Electrolyte and Hypertension Division, Renal Division, Perelman School of Medicine, University of Pennsylvania, Hospital of the University of Pennsylvania, 3400 Spruce Street, 1 Founders, Philadelphia, PA 19104, USA. Electronic address: https://twitter.com/LiannAbuSalman.

出版信息

Med Clin North Am. 2022 Mar;106(2):269-283. doi: 10.1016/j.mcna.2021.11.004. Epub 2022 Feb 2.

DOI:10.1016/j.mcna.2021.11.004
PMID:35227430
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9728017/
Abstract

Hypertension is a major cause of cardiovascular morbidity and mortality globally. Many patients with hypertension have secondary causes of hypertension that merit further evaluation. For example, secondary hypertension can result in target organ damage to the heart, kidneys, and brain independent of the effects of blood pressure. Several causes benefit from targeted therapies to supplement first-line antihypertensive agents. However, secondary hypertension is often underrecognized. The goal of this review is to highlight optimal approaches to the diagnosis and management of common causes of secondary hypertension, including primary aldosteronism, renovascular hypertension, obstructive sleep apnea, and drug-induced hypertension.

摘要

高血压是全球心血管发病率和死亡率的主要原因。许多高血压患者存在继发性高血压病因,需要进一步评估。例如,继发性高血压可导致心脏、肾脏和大脑等靶器官损伤,且独立于血压的影响。某些病因通过针对特定病因的治疗可补充一线降压药物。然而,继发性高血压往往未被充分认识。本综述的目的是强调继发性高血压常见病因的诊断和管理的最佳方法,包括原发性醛固酮增多症、肾血管性高血压、阻塞性睡眠呼吸暂停和药物引起的高血压。